Key Points
Dhampur Bio Organics reported $4.86B revenue and $2.55 EPS on April 29
Stock gained 3.4% post-earnings, reaching $123.50 with year-to-date gains of 50.89%
Meyka AI rates DBOL.NS with B+ grade reflecting solid fundamentals and renewable energy positioning
Net income declined 68.4% year-over-year due to commodity margin pressure requiring profitability focus
Dhampur Bio Organics Limited (DBOL.NS) delivered solid earnings results on April 29, 2026, demonstrating resilience in India’s agricultural processing sector. The integrated sugarcane company reported $4.86 billion in revenue and $2.55 earnings per share, reflecting steady operational performance. The stock responded positively, climbing 3.4% to $123.50 in trading following the announcement. With a market capitalization of $7.93 billion, Dhampur Bio Organics continues to strengthen its position in refined sugar, biofuels, and renewable energy production. Meyka AI rates DBOL.NS with a grade of B+, suggesting the company maintains competitive fundamentals despite broader market challenges.
Earnings Results and Stock Performance
Dhampur Bio Organics delivered earnings that reflect steady business execution across its diversified product portfolio. The company reported $2.55 earnings per share and $4.86 billion in total revenue, demonstrating consistent operational output.
Revenue Performance
The $4.86 billion revenue figure showcases the company’s scale in India’s agricultural processing industry. This reflects strong demand for refined sugar, biofuels, and biomass-based renewable power products. The company’s integrated model allows it to capture value across the sugarcane supply chain.
Stock Market Reaction
Market participants responded favorably to the earnings release. DBOL.NS gained 3.4% or $4.06 per share, closing at $123.50. This positive reaction suggests investors view the results as meeting or exceeding expectations. Trading volume reached 117,507 shares, slightly below the average of 294,824, indicating moderate investor engagement.
Year-to-Date Performance
Dhampur Bio Organics has delivered impressive returns this year. The stock is up 50.89% year-to-date, significantly outperforming its 50-day moving average of $106.65. The 200-day moving average sits at $88.90, showing sustained upward momentum throughout 2026.
Financial Metrics and Valuation
Dhampur Bio Organics trades at reasonable valuations relative to its earnings power and cash generation capabilities. The company’s financial profile reveals both strengths and areas requiring attention.
Earnings and Profitability
With a P/E ratio of 33.56, the stock reflects investor confidence in future earnings growth. The company’s net profit margin of 1.17% indicates tight margins typical of commodity-based agricultural processing. However, the gross profit margin of 22.59% demonstrates solid pricing power on core products. Operating margins of 8.14% show effective cost management across production facilities.
Cash Flow Strength
Dhampur Bio Organics generates robust cash flows supporting operations and shareholder returns. Operating cash flow per share reached $103.77, while free cash flow per share totaled $100.84. These metrics indicate the company converts earnings into actual cash efficiently. The company maintains a dividend yield of 1.05%, paying $1.25 per share annually.
Balance Sheet Position
The company carries moderate leverage with a debt-to-equity ratio of 0.58. Current ratio of 1.13 suggests adequate short-term liquidity. Interest coverage of 2.48x indicates manageable debt service obligations, though limited cushion for operational disruptions.
Business Segments and Growth Drivers
Dhampur Bio Organics operates across multiple revenue streams, reducing dependence on any single product category. This diversification strategy supports long-term resilience and growth.
Core Sugar Business
Refined and raw sugar production remains the foundation of Dhampur’s operations. The company processes sugarcane into high-quality sugar products serving domestic and export markets. Strong agricultural commodity prices and steady domestic demand support this segment’s performance.
Biofuels and Renewable Energy
The company manufactures ethanol and food-grade alcohol (ENA) from sugarcane byproducts. Biomass-based renewable power generation leverages bagasse, a sugarcane processing residue. These segments benefit from India’s renewable energy targets and rising fuel demand.
Value-Added Products
Dhampur produces organic fertilizer and bagasse products from processing residues. Alcoholic beverages with 25% and 36% alcohol content add premium revenue streams. These higher-margin products improve overall profitability and reduce waste.
Outlook and Investment Considerations
Dhampur Bio Organics faces a mixed outlook shaped by commodity cycles, regulatory support, and operational execution. Investors should monitor several key factors moving forward.
Growth Prospects
The company’s three-year revenue growth of 19.63% demonstrates solid expansion trajectory. However, net income declined 68.4% year-over-year, reflecting margin compression from commodity price volatility. Management must balance volume growth with profitability improvement. Renewable energy investments position the company well for India’s clean energy transition.
Risk Factors
Sugarcane prices and agricultural commodity volatility directly impact margins. Regulatory changes in alcohol production or sugar exports could affect revenue streams. The company’s debt-to-market cap ratio of 0.71 indicates meaningful leverage relative to market value. Competition from larger sugar producers and alternative biofuel sources poses ongoing challenges.
Meyka AI Assessment
Meyka AI rates DBOL.NS with a B+ grade, reflecting solid fundamentals balanced against execution risks. The rating suggests the stock offers reasonable value for investors seeking exposure to India’s agricultural processing sector. However, the company’s D+ fundamental rating from other analysts highlights concerns about profitability metrics and return on equity.
Final Thoughts
Dhampur Bio Organics delivered steady earnings results with $4.86 billion revenue and $2.55 EPS, earning a positive 3.4% stock price reaction. The company’s diversified business model across sugar, biofuels, and renewable energy provides resilience, though net income declined 68.4% year-over-year due to commodity margin pressure. With a B+ Meyka AI grade, the stock offers reasonable value for investors, supported by strong cash flow generation and India’s renewable energy tailwinds. However, the D+ fundamental rating from other metrics and 0.58 debt-to-equity ratio warrant careful monitoring. Investors should track sugarcane prices, regulatory developments, and profitability recovery in coming quarters.
FAQs
Did Dhampur Bio Organics beat or miss earnings estimates?
Dhampur reported $4.86B revenue and $2.55 EPS with no published estimates available. The stock gained 3.4% post-earnings, suggesting positive market reception. The company demonstrated solid operational execution across sugar, biofuels, and renewable energy segments.
What is Meyka AI’s rating for DBOL.NS?
Meyka AI rates DBOL.NS with a B+ grade, indicating solid fundamentals and reasonable value. The rating reflects the company’s diversified business model, strong cash flow generation, and positioning in India’s renewable energy sector, balanced against profitability challenges.
How did the stock price react to earnings?
DBOL.NS gained 3.4% or $4.06 per share, closing at $123.50 on April 29, 2026. The positive reaction reflects investor confidence in the company’s results. Year-to-date, the stock is up 50.89%, significantly outperforming its 50-day moving average.
What are the main risks for Dhampur Bio Organics?
Key risks include sugarcane price volatility affecting margins, regulatory changes in alcohol production, and competition from larger producers. The company’s 0.58 debt-to-equity ratio and 68.4% net income decline year-over-year warrant monitoring for profitability recovery.
What is the company’s dividend yield?
Dhampur Bio Organics offers a 1.05% dividend yield, paying $1.25 per share annually. The payout ratio of 35% indicates sustainable dividends with room for reinvestment in growth initiatives and debt reduction.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)